Assembly, characterization, and delivery of quantum dot labeled biotinylated 
lipid particles.

Sigot, V.

doi:10.1007/978-1-4939-1280-3_9

Item

ITEM ACTIONSEXPORT

Add to Basket

Local TagsRelease HistoryDetailsSummary

Released

Book Chapter

Assembly, characterization, and delivery of quantum dot labeled biotinylated lipid particles.

MPS-Authors

/persons/resource/persons15835

Sigot, V.
Department of Molecular Biology, MPI for biophysical chemistry, Max Planck Society;

External Resource

http://link.springer.com/content/pdf/10.1007%2F978-1-4939-1280-3_9.pdf
(Publisher version)

Fulltext (restricted access)

There are currently no full texts shared for your IP range.

Fulltext (public)

2070913.pdf
(Publisher version), 722KB

Supplementary Material (public)

There is no public supplementary material available

Citation

Sigot, V. (2014). Assembly, characterization, and delivery of quantum dot labeled biotinylated lipid particles. In A. Fontes, & B. S. Santos (Eds.), Quantum dots: Applications in biology (pp. 113-127). New York, N.Y.: Springer. doi:10.1007/978-1-4939-1280-3_9.

Cite as: https://hdl.handle.net/11858/00-001M-0000-0024-34F6-B

Abstract

Lipid nanoparticles composed of mixtures of PEGylated-lipids; cationic and neutral lipids prepared by detergent dialysis can encapsulate biological active molecules and show considerable potential as systemic therapeutic agents. Addition of biotinylated lipids to this formulation allows surface modification of these particles with a suitable ligand or probe conjugated to streptavidin for specific cell targeting. Monitoring long circulating particles and cellular uptake requires stable and bright fluorescent probes. Quantum dots (QDs) constitute a relatively new class of fluorescent probes that overcome the limitations of organic fluorophores in biological imaging applications. Here, a protocol for the encapsulation of QD655 (red) in biotinylated lipid particles (BLPs) prepared by a detergent dialysis technique is presented followed by characterization of the loaded liposomal vehicles. Then, a protocol for BLPs surface modification via biotin-streptavidin linkage with preformed complexes of ligand-QD525 (green) for specific cell targeting of the nanoparticle is detailed. Conditions for cell binding and uptake of two colors QD labeled BLPs as well as basic microscopic settings for confocal live cell imaging are described.